Cargando…
Long-term Pegylated Interferon-α-2a Treatment for Chronic Hepatitis C in an Elderly Renal Transplant Recipient: Case Report and Literature Review
Combination treatment of pegylated interferon (PEG-IFN) plus ribavirin for renal transplant recipients (RTRs) with hepatitis C virus (HCV) infection remains controversial, as it has been associated with a high risk of rejection, resulting in graft loss and a reduction in patient survival. We present...
Autores principales: | Zheng, Ming-Hua, Chen, Yong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602826/ https://www.ncbi.nlm.nih.gov/pubmed/25569669 http://dx.doi.org/10.1097/MD.0000000000000390 |
Ejemplares similares
-
First Case Report of Acute Renal Failure After Mesh-Plug Inguinal Hernia Repair in a Kidney Transplant Recipient
por: Veroux, Massimiliano, et al.
Publicado: (2016) -
Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009) -
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
por: Ollivier-Hourmand, I., et al.
Publicado: (2020) -
Risk factors and outcomes associated with a higher use of inotropes in kidney transplant recipients
por: Choi, Jae Moon, et al.
Publicado: (2017) -
The short-term and long-term outcomes of transcatheter or surgical aortic valve replacement in elderly patients: A protocol for a systematic review
por: Lei, Xiang, et al.
Publicado: (2020)